Zynerba Pharmaceuticals, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Zynerba Pharmaceuticals, Inc.
CIK #0001621443
EDGAR Form CIK 2011 - 2025
10-K [0001621443]
10-Q [0001621443]
3 [0001621443]
4 [0001621443]
8-K [0001621443]
D [0001621443]
SC 13D [0001621443]
SC 13G [0001621443]
Form 13D/13G Filer Form 13D/13G Subject Filed
Beryl Capital Management LLC Zynerba Pharmaceuticals Inc [2023-09-05]
Harmony Biosciences Holdings Inc Zynerba Pharmaceuticals Inc [2023-08-24]
Vanguard Group Inc Zynerba Pharmaceuticals Inc [2020-02-11]
BlackRock Inc Zynerba Pharmaceuticals Inc [2020-02-07]
ETF Managers Group LLC Zynerba Pharmaceuticals Inc [2019-06-04]
BlackRock Inc Zynerba Pharmaceuticals Inc [2018-02-01]
Perceptive Advisors LLC Zynerba Pharmaceuticals Inc [2017-02-14]
Cormorant Asset Management LLC Zynerba Pharmaceuticals Inc [2017-01-30]
Cormorant Global Healthcare Master Fund LP Zynerba Pharmaceuticals Inc [2016-03-04]
Rapp Michael Zynerba Pharmaceuticals Inc [2016-02-16]
RA Capital Management LLC Zynerba Pharmaceuticals Inc [2015-10-14]
Benovitz Ethan Zynerba Pharmaceuticals Inc [2015-08-14]
Form 3/4/5 Subject 2011 - 2025
Zynerba Pharmaceuticals, Inc.
Sebree Terri B
Fickenscher James E
Stephenson Pamela
Jones Kenneth T
Anido Armando
Kisner Daniel L
Parker Albert P
Cooper Warren D
Butler John P.
View All
Terms | Privacy | Guide
tony@aum13f.com